ANTICONVULSANT EVALUATION 1,2,4 PYRIDINE-TRIAZOLE BASED SCHIFF BASE DERIVATIVES TARGETING THE GABA-A RECEPTOR: IN SILICO, IN VITRO AND IN VIVO STUDIES
: Epilepsy affects over 50 million individuals worldwide and is characterized by recurrent seizures that are sometimes unresponsive to current therapies and induce negative effects, underscoring the urgent need for new anticonvulsant medications. This study examines the anticonvulsant effects of 1,2,4 pyridine triazole...